Form 4: GoodRx Holdings Director Kelly J. Kennedy Reports Acquisition of Class A Common Stock

Director Kelly J. Kennedy acquired 2,464 shares of GoodRx Holdings, Inc. Class A common stock on July 8, 2024, and holds 30,862 shares.

Summary

• On July 8, 2024, Kelly J. Kennedy, a director of GoodRx Holdings, Inc., acquired 2,464 shares of Class A common stock.
• The acquisition was made at a price of $0 per share.
• Following the transaction, Kennedy directly owns 30,862 shares of Class A common stock.
• The reported transaction also involves restricted stock units that vest in full on the earlier of June 6, 2025, and the date of the 2025 Annual Meeting of Stockholders, subject to continued service.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, and the transaction itself doesn't inherently indicate positive or negative sentiment. It reflects an insider's activity, which could be interpreted in various ways.

Positives

• The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The restricted stock units vest in the future, contingent on continued service, indicating a long-term commitment.

Industry Context

This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency to the market regarding their transactions in the company's stock.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their insiders.
• The information disclosed is consistent with regulatory requirements for reporting changes in beneficial ownership.

Key Dates